The American Society of Dermatopathology

Dermatopathology Appropriate Use Criteria


In 2015, under the vision of then Society President, Dr. Dirk Elston, the Appropriate Use Criteria (AUC) Task Force was created to help guide dermatopathologists and inform their clinical colleagues in their use of ancillary studies performed in dermatopathology in specific clinical scenarios with overarching goal of producing high quality care, lowering costs and ensuring efficient use of laboratory resources.

The Task Force identified ancillary studies performed in dermatopathology encompassing four broad areas in which AUC could be developed. These included: lymphoproliferative, melanocytic, soft tissue, and other, which includes entities that do not fit into one of the aforementioned groups. Using the methodology developed by RAND/ UCLA, which combines best scientific evidence with expert opinion to develop patient-centered guidelines (appropriateness ratings), the Task Force explored 12 ancillary studies used in dermatopathology and 211 clinical scenarios that are commonly encountered in dermatopathology.

Appropriateness recommendations are published in the Journal of Cutaneous Pathology with an abbreviated version published in the Journal of the American Academy of Dermatology. The intent of the AUC is to provide guidance to physicians' in test selection in commonly encountered clinical scenarios. Still, the selected wording of the appropriateness ratings allows for individualization in diagnostic test selection, which is dependent on the clinical scenario at hand. 

The Task Force was transitioned to a standing Committee in 2017, and along with working on dissemination of the developed AUC, the committee identified areas, which have a potential for misuse and are supported by evidence, which could be converted into recommendations for the Choosing Wisely Campaign. The recommended list was reviewed and approved by the ASDP Ethics Committee and Board of Directors.

Since then, the ASDP’s AUC in dermatopathology have been published in multiple peer-reviewed journals, in medical blogs and used to create recommendations that can be found on the on the Choosing Wisely website.

The ASDP is committed to making sure the AUC  stay relevant to dermatopathology and updates are already in the works.

Manuscripts with appropriateness recommendations:

Journal of Cutaneous Pathology

Journal of the American Academy of Dermatology 

Literature review manuscripts:

 

AUC Task Force / Committee 
M. Yadira Hurley (Chair)  
Claudia I. Vidal, MD, PhD (Vice chair)  
Aleodor A. Andea, MD, MBA
Angela Bohlke, MD
Nneka I. Comfere, MD  
Sarah Hughes, MD  
Jinah Kim, MD, PhD  
Jessica A. Kozel, MD  
Jason B. Lee, MD
Konstantinos Linos, MD  
Brandon Litzner, MD
Tricia Missall, MD, PhD
Roberto A. Novoa, MD    
Brian L. Swick, MD
Uma N. Sundram, MD, PhD  
 
2019-2019 AUC Committee
Claudia I. Vidal, MD, PhD (Chair)   
Maxwell Fung, MD (Vice Chair)
Aleodor A. Andea, MD, MBA  
Nneka I. Comfere, MD    
Patrick Oliver Munroe Emanuel MB, ChB, Dip Arts
Tammie C. Ferringer, MD
Alex Hristov, MD
Sarah Hughes, MD 
Jinah Kim, MD, PhD 
Scott Laurer, MD
Konstantinos Linos, MD
Tricia Missall, MD, PhD
Roberto A. Novoa, MD   
Rajiv Patel, MD
Sara Shalin, MD, PhD
Uma N. Sundram, MD, PhD 
Mike Tetzlaff, MD, PhD

Interested in joining the ASDP Appropriate Use Criteria Committee?
Contact ASDP headquarters at info@asdp.org.